Related Experiment Videos
[Studies on Epstein-Barr virus strain differences with monoclonal antibodies]
Summary
Researchers developed a new monoclonal antibody to identify an early membrane antigen specific to the H18 Epstein-Barr virus (EBV) strain. This antibody targets key viral polypeptides, aiding in differentiating EBV strains.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Context:
- Epstein-Barr virus (EBV) strains exhibit genetic diversity, necessitating methods for precise differentiation.
- Monoclonal antibodies are crucial tools for identifying specific viral antigens and characterizing viral strains.
Purpose:
- To develop and characterize a monoclonal antibody capable of distinguishing a novel EBV strain (H18) from other EBV strains.
- To identify the specific EBV antigens recognized by the developed monoclonal antibody.
Summary:
- A hybridoma line produced monoclonal antibodies against the H18 EBV membrane antigen (MA).
- The T14-11 antibody was selected for its ability to neutralize EBV in vitro and recognize polypeptides P220, P175, and P140 in purified H18 EBV particles via Western Blot.
- Indirect immunofluorescence confirmed the presence of these polypeptides on the plasma membrane and in the cytoplasm, with expression abolished by puromycin treatment, indicating specificity for an early EBV membrane antigen.
Impact:
- This research provides a specific immunological tool for the identification and characterization of the H18 EBV strain.
- The findings contribute to a better understanding of EBV antigen structure and expression, potentially aiding in diagnostics and antiviral strategies.